Contribution of PD-L1 to oncogenesis of lymphoma and its RNAi-based targeting therapy (Q39371874)

11 September 2017

title

Contribution of PD-L1 to oncogenesis of lymphoma and its RNAi-based targeting therapy (English)

1 reference

11 September 2017

Yi Li

1

1 reference

11 September 2017

Jing Wang

series ordinal

2

1 reference

11 September 2017

Chong Li

series ordinal

3

1 reference

11 September 2017

Xiao-Yan Ke

series ordinal

4

1 reference

11 September 2017

publication date

30 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

53

1 reference

11 September 2017

issue

10

1 reference

11 September 2017

page(s)

2015-2023

1 reference

The epidemiology of non-Hodgkin's lymphoma

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

PD-1 and PD-1 ligands: from discovery to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.673228

10.3109/10428194.2012.673228

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference